• Conference Recording
  • On-Demand
  • Adiposity Related Diseases
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
The gut microbiome is recognized as an important factor in obesity. This webinar will review the interconnection between obesity and the gut microbiome.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Obesity is emerging as a serious and complex health condition affecting about 1 billion people in the world.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
  • 1.00 AMA PRA Category 1 Credit
  • Recorded Webinar
  • On-Demand
  • Adiposity Related Diseases
 
  • 1.00 AMA PRA Category 1 Credit

Pages